Thursday, October 28, 2010: 1:00 PM-3:30 PM
3.1
Resilience and Posttraumatic Stress Disorder After the 1988 Earthquake in Armenia
Louis Najarian, M.D.
New York Univesity School of Medicine, Manhasset, NY
Ilana Barry, M.S.
Long Island University, New York, NY
Suzanne Sunday, Ph.D.
Feinstein Institute for Medical Research, Manhasset, NY
Victor Labruna, Ph.D.
North Shore University Hospital, Manhasset, NY
3.2
Community-Based Telehealth to Prevent Mental Health Problems in Rural Youth
Susana Helm, Ph.D.
University of Hawai'i John A. Burns School of Medicine, Honolulu, HI
Darryl Salvador, Psy.D.
Molokai Community Health Center; Molokai Ohana Health Care Inc., Kaunakakai, HI
Deborah Goebert, DrPH
Queens Medical Center, Honolulu, HI
Desiree Puhi, R.N.
Molokai Community Health Center; Molokai Ohana Health Care Inc., Kaunakakai, HI
Ian Chun, M.D.
, Waipahu, HI
Michael Fukuda, M.S.W.
University of Hawai'i, Honolulu, HI
3.3
25-OH Vitamin D Deficiency Associated with Psychotic Features in Acutely Mentally Ill Adolescents
Barbara Gracious, M.D.
University of Rochester Medical Center, Rochester, NY
Teresa L. Finucane, M.S.
University of Rochester Medical Center, Rochester, NY
Meriel Friedman-Campbell
University of Rochester Medical Center, Rochester, NY
Susan Messing, B.S.
University of Rochester Medical Center, Rochester, NY
Melissa Parkhurst, B.A.
University of Rochester Medical Center, Rochester, NY
3.4
An Objective-Setting Program to Promote Mental Health in Secondary Schools
Antonella Gigantesco, Psy.D.
Italian National Institute of Health, Roma Italy
3.5
Pediatric Patients' Opinions about Suicide Screening in an Emergency Department
Abigail Bosk, B.A.
National Institute of Mental Health, Bethesda, MD
Lisa Horowitz, M.P.H., Ph.D.
National Institute of Mental Health, Bethesda, MD
Elizabeth Ballard, M.A.
National Institute of Mental Health, Bethesda, MD
Deborah Snyder, L.C.S.W., M.S.W.
National Institute of Mental Health, Bethesda, MD
Maryland Pao, M.D.
National Institute of Mental Health and National Institutes of Health, Bethesda, MD
3.6
Anxiety in Children and Adolescents at High-Risk for Bipolar Disorder
Elizabeth G. Adams, B.A.
Stanford University, Palo Alto, CA
Meghan E. Howe, M.S.W.
Stanford University, Stanford, CA
Victoria E. Cosgrove, Ph.D.
Stanford University School of Medicine, Palo Alto, CA
Tenah K. Acquaye, B.A.
Stanford University, Palo Alto, CA
Cheri Dijamco, B.A.
Stanford University, Palo Alto, CA
Gloria Koskey
Stanford University, Palo Alto, CA
Erica M. Sanders
Stanford University, Palo Alto, CA
Kiki D. Chang, M.D.
Stanford University School of Medicine, Palo Alto, CA
3.7
Family Skills Training for Pediatric Consultation Liaison Psychiatry (Pediatric Psychosomatic Medicine)
Paul M. Jones, M.D.
Georgetown University, Washington, DC
Karen M. Johnson, M.D.
Medstar - Washington Hospital Center, Washington, DC
Maryland Pao, M.D.
National Institute of Mental Health and National Institutes of Health, Bethesda, MD
3.8
Spatial Distribution and Factors Associated with Stress Among Adolescents in Banpeaw District, Samutsakhorn Province, Thailand: Using Geographic Information System (GIS)
Suporn Apinuntavech, M.D.
Mahidol University, Bangkok Thailand
Kittipong Hancharoen, Ph.D.
Mahidol University, Bangkok Thailand
Tuanjai Nuchtean, M.S.C.
Department of Disease Control, Ministry of Public Health, Nontaburi Thailand
Sukhontha Siri, Ph.D.
Mahidol University, Bangkok Thailand
3.9
Similarities and Differences Among Adolescents Who Communicate Suicidality to Others Via Electronic Versus Other Means
Erin L. Belfort, M.D.
Harvard Longwood Psychiatry Residency Training Program, Boston, MA
Katherine Ginnis, M.P.H., M.S.W.
Children's Hospital Boston, Boston, MA
Enrico Mezzacappa, M.D.
Children's Hospital Boston, Boston, MA
3.10
Psychoeducational Approach to First Psychotic Episodes in Children and Adolescents
A. Calvo, M.S.
Hospital General Universitario Gregorio Marañón. Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Madrid Spain
Marta Rapado-Castro, Ph.D.
Hospital General Universitario Gregorio Maranon. Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid Spain
M. Mayoral, Ph.D.
Hospital General Universitario Gregorio Marañón. Centro de Investigación Biomédica en Red.CIBERSAM., Madrid Spain
L. Miguel Moreno-Iniguez, M.D.
Hospital Infanta Sofia, Madrid Spain
C. Tapia, M.S.
, Madrid Spain
Carmen Moreno, M.D.
Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Madrid Spain
Ana María Ruiz Sancho, M.D.
Private Practice, Madrid Spain
C. Arango, M.D., Ph.D.
Hospital General Universitario Gregorio Marañon, CIBERSAM, Madrid Spain
3.11
Gender Related Differences of Parental Supervision of Video Game Use in a Clinical Sample of Latino Adolescents
Luz N. Colón-de Martí, M.D.
University of Puerto Rico School of Medicine, San Juan, PR
Linnette Rodríguez-Figueroa, M.S., Ph.D.
University of Puerto Rico, Graduate School of Public Health, San Juan, PR
Lelis L. Nazario, M.D.
Roberto Gutierrez, M.D.
, San Juan, PR
Alexis T. Gonzalez, M.D.
, Carolina, PR
3.14
Healthcare Needs Among U.S. Children with Tourette's Disorder and the Contribution of Co-Occurring Mental, Emotional and Behavioral Problems
Rebecca H. Bitsko, Ph.D.
Centers for Disease Control and Prevention, Atlanta, GA
Susanna Visser, M.S.
Centers for Disease Control and Prevention, Atlanta, GA
Lawrence Scahill, M.S.N., Ph.D.
Yale Child Study Center, New Haven, CT
Melissa L. Danielson, M.P.H.
Centers for Disease Control and Prevention, Atlanta, GA
3.15
Body Dysmorphic Disorder in Adolescents: Prevalence and Clinical Characteristics in Inpatients
Jennifer Dyl, Ph.D.
Brown University Warren Alpert School of Medicine/ E.P. Bradley Hospital, East Providence, RI
Jennifer Kittler, Ph.D.
Brown University Warren Alpert School of Medicine/ E.P. Bradley Hospital, Riverside, RI
Beth L.G. Hollander, M.A.
Hofstra University, Dix Hills, NY
Jeffrey Hunt, M.D.
The Warren Alpert Medical School of Brown University, Riverside, RI
Anthony Spirito, Ph.D.
Brown University Center for Alcohol and Addiction Studies, Providence, RI
Ronald Seifer, Ph.D.
The Warren Alpert Medical School of Brown University, East Providence, RI
Katharine A. Phillips, M.D.
Warren Alpert Medical School of Brown University, Providence, RI
3.16
Momentary Positive and Negative Affect Predict Sexual Intercourse in Depressed Youth
Lydia A. Shrier, M.D., M.P.H.
Children's Hospital Boston, Boston, MA
Henry A. Feldman, Ph.D.
Children's Hospital Boston, Boston, MA
Shimrit K. Black, M.A.
Temple University, Philadelphia, PA
Courtney Walls, M.P.H.
Children's Hospital Boston, Boston, MA
Ashley D. Kendall, B.A.
Children's Hospital Boston, Boston, MA
Christopher Lops, M.A.
Children's Hospital Boston, Boston, MA
William R. Beardslee, M.D.
Children's Hospital Boston, Boston, MA
3.17
New Media Use and Risk Behaviors Among Urban African American Adolescents
Laura Whiteley, M.D.
, Pawtucket, RI
Larry K. Brown, M.D.
Brown University, Providence, RI
Rebecca Swenson, Ph.D.
Brown University, Providence, RI
Daniel Romer, Ph.D.
University of Pennsylvania, Philadelphia, PA
3.18
Gender Differences in Correlates of Conduct Problems in a Sample of 6-9 Year Old Children Receiving Special Educational Services for Disruptive Behavior
Michele Dery, Ph.D.
University of Sherbrooke, Sherbrooke, QC
Jean M. Toupin, Ph.D.
University of Sherbrooke, Sherbrooke, QC
Pierrette Verlaan, Ph.D.
University of Sherbrooke, Sherbrooke, QC
3.20
I Eat, Therefore I Am: A Case for Nutritional Analysis in the Care of Disruptive Behavior Disorders
Jean C.J. Loo, B.S.
Institute of Mental Health, Singapore Singapore
Wei Shyan Lim, B.A., B.S., M.S.
Institute of Mental Health Singapore
Delia H.Y. Yang, B.S.
Institute of Mental Health, Singapore Singapore
Nikki S.J. Lim, B.A., M.A.
Institute of Mental Health, Singapore Singapore
Widiaty Caroline, M.D.
Institute of Mental Health, Singapore Singapore
Liying Su, B.A.
Institute of Mental Health, Singapore Singapore
Choon Guan Lim, M.D.
, Singapore Singapore
Daniel Shuen Sheng Fung, M.D.
Institute of Mental Health, Singapore Singapore
3.21
When Will Boys Be Boys and Girls Be Girls?: Variations in Young Girls' and Boys' Disruptive Behavior Across Social Interactional Contexts
Sarah A. O. Gray, B.A.
University of Massachusetts Boston, Boston, MA
Alice S. Carter, Ph.D.
University of Massachusetts Boston, Boston, MA
Margaret Briggs-Gowan, Ph.D.
University of Connecticut Health Center, Glastonbury, CT
Carri Hill, Ph.D.
Lauren S. Wakschlag, Ph.D.
Northwestern University, Chicago, IL
3.22
Effect of Prior Antipsychotic Exposure on Weight Gain During Aripiprazole Treatment of Irritability Associated with Autistic Disorder
Gwendolyn G. Stockton, B.A., B.S., Pharm.D.
Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ
George Manos, Ph.D.
Bristol Myers Squibb, Wallingford, CT
Robert A. Forbes, Ph.D.
Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ
Randall Owen, M.D.
Bristol Myers Squibb, Wallingford, CT
Raymond Mankoski, M.D., Ph.D.
Bristol Myers Squibb, Plainsboro, NJ
3.23
Description of Baseline Medication Prescriptions in Youths with Elevated Symptoms of Mania
Robert A. Kowatch, M.D., Ph.D.
Cincinnati Children's Hospital, Cincinnati, OH
Eric Youngstrom, Ph.D.
University of North Carolina at Chapel Hill, Chapel Hill, NC
Nicole Cicchino, B.S.
Cincinnati Children's Hospital, Cincinnati, OH
Judith Depew
Cincinnati Children's Hospital, Cincinnati, OH
Kathleen M. Robbins, M.A.
Cincinnati Children's Hospital, Cincinnati, OH
Jennifer S. Combs, M.S.W.
Cincinnati Children's Hospital, Cincinnati, Oh
3.24
Antidepressant-Induced Mood Dysregulation and Its Association with CYP450 Enzyme Alterations
Lisa B. Namerow, M.D.
Institute of Living, Hartford Hospital, Hartford, CT
Allana R. Lee, D.O.
, Manchester, CT
David V. Villagra, B.A.
Genomas, Hartford, CT
Andreas Windemuth, Ph.D.
Genomas, Hartford, CT
Gualberto Ruano, M.D.
Genomas, Hartford, CT
3.25
Prosocial Behavior and Psychopathology of Children and Adolescents with and without Parental Support in the District of Kailahun in Sierra Leone
Richard Neugebauer, M.P.H., Ph.D.
New York State Psychiatric Institute, New York, NY
Alice Behrendt, M.A.
Plan International, Dakar Ponty Senegal
Monica Ghailian, M.A.
Columbia University Teachers College, New York, NY
Enrico Suardi, M.D., M.S.
State University of New York, Syracuse, NY
3.26
Prevalence Estimates of Mental Health Psychopathologies and Inter-Rater Agreement in 6-11 Year Old Primary School Children
Isabelle Ellen Pitrou, M.D., M.S.C.
Descartes University, Paris France
Taraneh Shojaei, M.D.
Agence de la Biomédecine, Saint-Denis La Plaine Cedex France
Ashley Wazana, M.D., F.R.C.P.
Jewish General Hospital, McGill University, Montreal, QC
Anders Boyd, M.P.H.
Descartes University, Paris France
Viviane Kovess-Masfety, M.D., Ph.D.
Descartes University, Paris France
3.28
Nonmedical Use Surveillance and Signal Identification of Lisdexamfetamine Dimesylate, A Prodrug Stimulant for the Treatment of ADHD
Sajan Varughese, M.B.A., Pharm.D.
Shire Development Inc., Wayne, PA
Susan Rosen, M.D.
Shire Development Inc., Wayne, PA
Anders Lindholm, M.D., Ph.D.
Shire Development Inc., Wayne, PA
Michelle D. Ertischek, M.P.H.
Pinney Associates Inc., Bethesda, MD
Mark A. Sembower, M.S.
Pinney Associates Inc., Pittsburgh, PA
Sidney H. Schnoll, M.D., Ph.D.
Pinney Associates Inc., Bethesda, MD
3.29
Parental Age and Risk of Autism in a Finnish Population
Katja M. Lampi, M.S.
University of Turku, Turku Finland
Susanna Hinkka-Yli-Salomäki, M.S.
University of Turku, Turku Finland
Hans Helenius, M.S.C.
University of Turku, Turku Finland
Alan S. Brown, M.D., M.P.H.
Columbia University, New York, NY
Andre Sourander, M.D., Ph.D.
University of Turku, Turku Finland
3.30
Childhood Bullying as a Predictor for Becoming a Teenage Mother in Finland
Venla Lehti, M.D.
University of Turku, Turku Finland
Andre Sourander, M.D., Ph.D.
University of Turku, Turku Finland
Anat Brunstein Klomek, Ph.D.
Interdisciplinary Center (IDC) Herzliya, Herzliya Israel
Solja Niemelä, M.D.
University of Turku, Turku Finland
Lauri H. Sillanmäki
University of Turku, Turku Finland
Jorma Piha, M.D., Ph.D.
University of Turku, Turku Finland
Kirsti Kumpulainen, M.D., Ph.D.
University of Eastern Finland, Kuopio Finland
Tuula Tamminen, M.D., Ph.D.
European Society of Child and Adolescent Psychiatry (ESCAP), Tampere Finland
Irma K. Moilanen, Ph.D.
University of Oulu, Oulu Finland
Fredrik Almqvist, M.D.
University of Helsinki, Helsinki Finland
3.31
Psychiatric Disorder and Violent Perpetration Among Delinquent Youth: A Longitudinal Study
Katherine S. Elkington, Ph.D.
Columbia University, New York State Psychiatric Institute, New York, NY
Leah J. Welty, Ph.D.
Northwestern University, Chicago, IL
Karen M. Abram, Ph.D.
Northwestern University, Feinberg School of Medicine, Chicago, IL
Linda A. Teplin, Ph.D.
Feinberg School of Medicine, Northwestern University, Chicago, IL
3.32
Conduct Disorder and Adult Psychiatric Diagnoses: Associations and Gender Differences in the U.S. Adult Population
Carmen Morcillo, M.D.
Columbia University, New York, NY
Cristiane S. Duarte, M.P.H., Ph.D.
Columbia University, New York State Psychiatric Institute, New York, NY
Shuai Wang, Ph.D.
New York State Psychiatric Institute, New York, NY
Carlos Blanco, M.D., Ph.D.
New York State Psychiatric Institute, New York, NY
3.33
Service Utilization for Children in the Longitudinal Assessment of Manic Symptoms (LAMS) Study
Amy N. Mendenhall, M.S.W., Ph.D.
University of Kansas, Lawrence, KS
Mary A. Fristad, A.B.P.P., Ph.D.
Ohio State University, Columbus, OH
Christine A. Demeter, M.A.
Case Western Reserve University, Cleveland, OH
Robert L. Findling, M.D.
University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH
Thomas W. Frazier, Ph.D.
Children's Hospital, Cleveland Clinic, Cleveland, OH
Eric Youngstrom, Ph.D.
University of North Carolina at Chapel Hill, Chapel Hill, NC
L. Eugene Arnold, M.D.
Ohio State University, Columbus, OH
Boris Birmaher, M.D.
Western Psychiatric Institute and Clinic, Pittsburgh, PA
Mary Kay Gill, J.D., M.S., R.N.
Western Psychiatric Institute and Clinic, Pittsburgh, PA
David Axelson, M.D.
University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, Pittsburgh, PA
Robert A. Kowatch, M.D., Ph.D.
Cincinnati Children's Hospital, Cincinnati, OH
Sarah M. Horwitz, Ph.D.
Stanford University School of Medicine, Stanford, CA
3.34
Childhood Predictors of Later Psychiatric Hospital Treatment: Findings From the Finnish Nationwide 1981 Birth Cohort Study
David Gyllenberg, M.D.
University of Helsinki, Helsinki Finland
Andre Sourander, M.D., Ph.D.
University of Turku, Turku Finland
Solja Niemelä, M.D.
University of Turku, Turku Finland
Hans Helenius, M.S.C.
University of Turku, Turku Finland
Lauri H. Sillanmäki
University of Turku, Turku Finland
Jorma Piha, M.D., Ph.D.
University of Turku, Turku Finland
Kirsti Kumpulainen, M.D., Ph.D.
University of Eastern Finland, Kuopio Finland
Tuula Tamminen, M.D., Ph.D.
European Society of Child and Adolescent Psychiatry (ESCAP), Tampere Finland
Irma K. Moilanen, Ph.D.
University of Oulu, Oulu Finland
Fredrik Almqvist, M.D.
University of Helsinki, Helsinki Finland
3.35
The Use of Electroconvulsive Therapy in Children and Adolescents at a Large Academic Center
Laura Gilley-Hensley, M.D.
University of Utah Neuropsychiatric Institute, Salt Lake City, UT
Lowry A. Bushnell, M.D.
University of Utah Neuropsychiatric Institute, Salt Lake City, UT
Kelly W. Smith, M.D.
University of Utah, Salt Lake City, UT
Howard R. Weeks, M.D.
University of Utah Neuropsychiatric Institute, Salt Lake City, UT
3.36
The Family Life Questionnaire: The Construction and Validation of a Novel Measure of Family Functioning
Tamsin Ford, M.B.B.S., M.R.C.Psych., M.S., Ph.D.
Peninsula Medical School, University of Exeter, Exeter United Kingdom
Anna Last, B.S.
University of Exeter, Exeter United Kingdom
William Henley, B.A., M.S.C., Ph.D.
Peninsula Medical School, University of Plymouth, Exeter United Kingdom
Robert Goodman, F.R.C.Psych., Ph.D.
King's College London Institute of Psychiatry, London United Kingdom
3.37
Parental Criminal Justice System Involvement and Psychiatric Disorders in Children: Longitudinal Study of Puerto Ricans in Two Contexts
Cristiane S. Duarte, M.P.H., Ph.D.
Columbia University, New York State Psychiatric Institute, New York, NY
Sa Shen, Ph.D.
Columbia Univeristy, New York State Psychiatric Institute, New York, NY
Ping Wu, M.D., Ph.D.
Columbia University, New York State Psychiatric Institute, New York, NY
Katharine C. Bernstein, M.A.
Columbia Univeristy, New York State Psychiatric Institute, New York, NY
Camilla S. Wasserman, M.A.
Columbia Univeristy, New York State Psychiatric Institute, New York, NY
Ernest Drucker, Ph.D.
John Jay College at City University of New York Psychology, New York, NY
Glorisa Canino, Ph.D.
University of Puerto Rico, Old San Juan, PR
Hector R. Bird, M.D.
Columbia University, San Juan, PR
3.38
Prevalence of Child and Adolescent Psychiatric Disorders in Chile: A National Community Epidemiological Study
Flora De la Barra, M.D.
Clinica las Condes. University of Chile, Santiago Chile
Benjamín Vicente
University of Concepción, Concepción Chile
Sandra Saldivia, D. Phil.
University of Concepción, Concepción, Octava Región
Pedro Rioseco, M.D.
University of Concepción, Concepción Chile
Roberto Melipillan, M.S.
University of Concepción, Concepcion Chile
3.40
Outpatient Children with Manic Symptoms: Who Are They?
Boris Birmaher, M.D.
Western Psychiatric Institute and Clinic, Pittsburgh, PA
Robert L. Findling, M.D.
University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH
David Axelson, M.D.
University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, Pittsburgh, PA
Eric Youngstrom, Ph.D.
University of North Carolina at Chapel Hill, Chapel Hill, NC
Mary A. Fristad, A.B.P.P., Ph.D.
Ohio State University, Columbus, OH
Sarah M. Horwitz, Ph.D.
Stanford University School of Medicine, Stanford, CA
Robert A. Kowatch, M.D., Ph.D.
Cincinnati Children's Hospital, Cincinnati, OH
L. Eugene Arnold, M.D.
Ohio State University, Columbus, OH
Christine A. Demeter, M.A.
Case Western Reserve University, Cleveland, OH
Mary Kay Gill, J.D., M.S., R.N.
Western Psychiatric Institute and Clinic, Pittsburgh, PA
Benjamin Fields, M.A.
The Ohio State University, Columbus, OH
Judith Depew
Cincinnati Children's Hospital, Cincinnati, OH
Shawn M. Kennedy, M.A.
Case Western Reserve University, Cleveland, OH
Linda Marsh, B.A.
Brieana M. Rowles, M.A.
Case Western Reserve University, Cleveland, OH
Thomas W. Frazier, Ph.D.
Children's Hospital, Cleveland Clinic, Cleveland, OH
Neal D. Ryan, M.D.
Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA
3.41
Improvement in Multiple Symptom Domains in Youth Following 12 Weeks of Atypical Antipsychotic Treatment for Irritability and Aggression
Cara M. Fosdick, M.D.
Washington University in St. Louis School of Medicine, Ann Arbor, MI
Ginger E. Nicol, M.D.
Washington University School of Medicine, Saint Louis, MO
Michael Yingling, B.S.
John W. Newcomer, M.D.
Washington University School of Medicine, St. Louis, MO
3.42
Factors Associated with Antidepressant Adherence for Medicaid Enrolled Children and Adolescents
Cynthia A. Fontanella, Ph.D.
The Ohio State University, Columbus, OH
Jeffrey Bridge, Ph.D.
The Research Institute at Nationwide Children's Hospital, Columbus, OH
Steven C. Marcus, Ph.D.
University of Pennsylvania, Philadelphia, PA
John V. Campo, M.D.
Nationwide Children's Hospital, The Ohio State University, Columbus, OH
3.43
Pharmacokinetics, Efficacy, and Safety of Two Modified Release Methylphenidate Formulations in Prepubertal Boys with ADHD: A Single-Blind, Randomized, Crossover Study
Christian Fleischhaker, M.D.
University Clinic Freiburg, Freiburg Germany
Klaus Hennighausen, M.D.
University Clinic Freiburg, Freiburg Germany
Katja Schneider-Momm, M.D.
University Clinic Freiburg, Freiburg Germany
Eberhard Schulz, M.D.
University Clinic Freiburg, Freiburg Germany
3.44
Weight Gain with Atypical Antipsychotics in Children and Adolescents: A Meta-Analysis
David Cohen Sr., M.D.
Université Pierre et Marie Curie, GH Pitié-Salpétrière, AP-HP, ISIR, Paris France
Olivier Bonnot Sr., M.D., Ph.D.
Université Pierre et Marie Curie, GH Pitié-Salpétrière, AP-HP, Paris France
Angele Consoli Sr., M.D., Ph.D.
Université Pierre et Marie Curie, GH Pitié-Salpétrière, AP-HP, Paris France
Nicolas Bodeau Sr., M.S.
Université Pierre et Marie Curie, GH Pitié-Salpétrière, AP-HP, Paris France
Claudine Laurent Sr., M.D., Ph.D.
Université Pierre et Marie Curie, GH Pitié-Salpétrière, AP-HP, CRICM, Paris France
3.45
Double-Blind Randomized Trial of Risperidone Versus Divalproex in Pediatric Bipolar Disorder
Julie A. Carbray, APRN, Ph.D., R.N.
University of Illinois at Chicago, Chicago, IL
Stephanie Parnes, B.A.
University of Illinois at Chicago, Chicago, IL
David B. Henry, Ph.D.
University of Illinois at Chicago, Chicago, IL
Robert L. Findling, M.D.
University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH
Tahseen Mohammed, M.D.
, Lombard, IL
Philip G. Janicak, M.D.
Rush University, Chicago, Il
John A. Sweeney, Ph.D.
University of Illinois at Chicago, Chicago, IL
Mani N. Pavuluri, M.D., FRANZCP, Ph.D.
Institute for Juvenile Research and Center for Cognitive Medicine, Chicago, IL
3.46
Long-Term Consequences on Height, Weight, Heart Rate, and Blood Pressure in Children Treated with Stimulants
Ulrich Brandstetter, M.D.
Develomental Neurology Mariestad, Skovde Sweden
Magnus K. Landgren, M.D., Ph.D.
Developmental Neurology, Mariestad, Skövde Sweden
Elisabeth Fernell, M.D., Ph.D.
Developmental Neurology, Mariestad, Skovde Sweden
3.47
A Six Months Naturalistic Study of Long-Acting Risperidone in Children and Adolescents with Bipolar Disorder
Miguel Angelo Boarati, M.D.
Child and Adolescent Affective Disorder Program at Institute of Psychiatry of University of Sao Paulo, Sao Paulo Brazil
Ana Rosa S. Cavalcanti, M.D.
Child and Adolescent Affective Disorder Program at Institute of Psychiatry of University of Sao Paulo, Sao Paulo Brazil
Ana Paula Ferreira Maia, M.D.
Child and Adolescent Affective Disorder Program at Institute of Psychiatry of University of Sao Paulo, Sao Paulo Brazil
Yuan-Pang Wang, M.D., Ph.D.
Section of Psychiatric Epidemiology at the Institute of Psychiatry, São Paulo Brazil
Lee Fu-I, M.D., Ph.D.
Child and Adolescent Affective Disorder Program at Institute of Psychiatry of University of Sao Paulo, Sao Paulo Brazil
3.48
An Open-Label Lithium Monotherapy Study in Bipolar I Disorder
Robert L. Findling, M.D.
University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH
Vivian Kafantaris, M.D.
The Zucker Hillside Hospital, Glen Oaks, NY
Mani N. Pavuluri, M.D., FRANZCP, Ph.D.
Institute for Juvenile Research and Center for Cognitive Medicine, Chicago, IL
Nora K. McNamara, M.D.
University Hospitals Case Medical Center, Cleveland, OH
Jon McClellan, M.D.
Seattle Children's Hospital, Seattle, WA
Jean A. Frazier, M.D.
University of Massachusetts Medical School, Newton, MA
Linmarie Sikich, M.D.
The University of North Carolina at Chapel Hill, Chapel Hill, NC
Robert A. Kowatch, M.D., Ph.D.
Cincinnati Children's Hospital, Cincinnati, OH
Jacqui Lingler, B.S.
University Hospitals Case Medical Center, Cleveland, OH
Jon Faber, M.A.
Case Western Reserve University, Cleveland, OH
Perdita Taylor-Zapata, M.D.
3.49
The Longitudinal Assessment of Manic Symptoms (LAMS) Study: Methods and Cohort Ascertainment
Robert L. Findling, M.D.
University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH
Eric Youngstrom, Ph.D.
University of North Carolina at Chapel Hill, Chapel Hill, NC
Mary A. Fristad, A.B.P.P., Ph.D.
Ohio State University, Columbus, OH
Boris Birmaher, M.D.
Western Psychiatric Institute and Clinic, Pittsburgh, PA
Robert A. Kowatch, M.D., Ph.D.
Cincinnati Children's Hospital, Cincinnati, OH
L. Eugene Arnold, M.D.
Ohio State University, Columbus, OH
Thomas W. Frazier, Ph.D.
Children's Hospital, Cleveland Clinic, Cleveland, OH
David Axelson, M.D.
University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, Pittsburgh, PA
Neal D. Ryan, M.D.
Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, PA
Christine A. Demeter, M.A.
Case Western Reserve University, Cleveland, OH
Mary Kay Gill, J.D., M.S., R.N.
Western Psychiatric Institute and Clinic, Pittsburgh, PA
Benjamin Fields, M.A.
The Ohio State University, Columbus, OH
Judith Depew
Cincinnati Children's Hospital, Cincinnati, OH
Shawn M. Kennedy, M.A.
Case Western Reserve University, Cleveland, OH
Linda Marsh, B.A.
Brieana M. Rowles, M.A.
Case Western Reserve University, Cleveland, OH
Sarah M. Horwitz, Ph.D.
Stanford University School of Medicine, Stanford, CA
3.50
Prevalence and Change in Psychiatric Disorders in a Sample of Perinatally HIV-Exposed Youth
Katherine S. Elkington, Ph.D.
Columbia University, New York State Psychiatric Institute, New York, NY
Claude A. Mellins, Ph.D.
Columbia Univeristy, New York State Psychiatric Institute, New York, NY
Cheng-Shiun Leu, Ph.D.
Columbia Univeristy, New York State Psychiatric Institute, New York, NY
Karina Santa-Maria, B.A.
Columbia Univeristy, New York State Psychiatric Institute, New York, NY
Curtis Dolezal, Ph.D.
Columbia Univeristy, New York State Psychiatric Institute, New York, NY
Andrew Wiznia, M.D.
Jacobi Medical Center and Albert Einstein College of Medicine, New York, NY
Elaine J. Abrams, M.D.
Columbia University and Harlem Hospital, New York, NY
Mahrukh Bamji, M.D.
New York Medical College, New York, NY
3.51
Safety and Tolerability of Aripiprazole in the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (6–17 Years Old): Results From a 52-Week Open-Label Study
Gina Lau, Pharm.D.
Otsuka America Pharmaceutical, Inc., Princeton, NJ
George Manos, Ph.D.
Bristol Myers Squibb, Wallingford, CT
Robert D. McQuade, Ph.D.
Otsuka Pharmaceutical Development and Commercialization, Inc., Princeton, NJ
Lisa M. Kamen, M.A.
Bristol Myers Squibb, Wallingford, CT
Ronald Marcus, M.D.
Bristol Myers Squibb, Wallingford, CT
Raymond Mankoski, M.D., Ph.D.
Bristol Myers Squibb, Plainsboro, NJ
3.52
A Placebo-Controlled Pilot Trial of Mecamylamine, A Nicotinic Receptor Agent, in the Treatment of Autism: Introduction of OACIS
Heather M. Liebherr, B.S.
Ohio University College of Osteopathic Medicine, Athens, OH
L. Eugene Arnold, M.D.
Ohio State University, Columbus, OH
Bethany Bates, B.A.
The Ohio State University, Columbus, OH
Xiaobai Li, Ph.D.
The Ohio State University, Columbus, OH
Michael G. Aman, Ph.D.
Ohio State University, Westerville, OH
Eric M. Butter, Ph.D.
Nationwide Children's Hospital, Westervillw, OH
3.53
Lithium for the Reduction of Aggression in Conduct Disorder: An Outpatient Study
Richard P. Malone, M.D.
Drexel University College of Medicine, Philadelphia, PA
Manely Ghaffari, M.D.
Drexel University College of Medicine, Philadelphia, PA
Susan H. West, Ph.D.
Drexel University College of Medicine, Philadelphia, PA
Beeta Verma, M.D.
Drexel University College of Medicine, Philadelphia, PA
Melissa Lech, B.S.
Drexel University College of Medicine, Philadelphia, PA
Jacqueline Cater, Ph.D.
Biomedical Statistical Consulting, Wynnewood, PA
3.55
Ziprasidone in Pediatric Bipolar Disorder: A 6-Week, Open-Label Comparison of Rapid vs. Slow Dose Titration
Kirti Saxena, M.D.
, Dallas, TX
Annie Walley
, Dallas, TX
Alexander D. Simmons, M.S.
Children's Medical Center Dallas, Dallas, TX
Paul A. Nakonezny, Ph.D.
University of Texas Southwestern Medical Center at Dallas, Dallas, TX
Cintly Celis-de Hoyos, B.A.
University of Texas at Arlington, Arlington, TX
Taryn Mayes, M.S.
University of Texas Southwestern Medical Center, Flower Mound, TX
Graham J. Emslie, M.D.
University of Texas Southwestern Medical Center at Dallas, Dallas, TX
3.56
Weight Gain in Illinois Foster Children Treated with Second Generation Antipsychotics
Deepti Singh, M.D.
University of Illinois at Chicago, Chicago, IL
Amber Rose Thompson, B.S.
University of Illinois at Chicago, Chicago, IL
Michael W. Naylor, M.D.
University of Illinois, Chicago, IL
Alice Gutierrez-Gottschalk, B.S., R.N.
University of Illinois at Chicago, Chicago, IL
Christine V. Davidson, Ph.D.
University of Illinois at Chicago, Chicago, IL
Qiaoyan Hu, M.S.
University of Illinois at Chicago, Chicago, IL
John M. Davis, M.D.
University of Illinois at Chicago, Chicago, IL
3.58
Improvement in Social Withdrawal and Global Measures of Behavior in Fragile X Syndrome: Results of a Randomized, Controlled, Phase 2 Trial of Arbaclofen
Jeremy Veenstra-VanderWeele, M.D.
Kennedy Center for Research on Human Development, Nashville, TN
Elizabeth Berry-Kravis, M.D., Ph.D.
Rush University, Chicago, IL
Barbara Rathmell, M.D.
Seaside Therapeutics, Inc., Cambridge, MA
Maryann Cherubini, B.S.
Seaside Therapeutics, Inc., Cambridge, MA
Peter Zarevics, B.S.
Seaside Therapeutics, Inc., Cambridge, MA
Paul Wang, M.D.
Seaside Therapeutics, Inc., Cambridge, MA
Randall L. Carpenter, M.D.
Seaside Therapeutics, Inc., Cambridge, MA
Mark Bear, Ph.D.
Howard Hughes Medical Institute and Massachusetts Institute of Technology, Cambridge, MA
Randi Hagerman, M.D.
University of California, Davis Medical Center, Sacramento, CA
3.59
Patterns in ADHD Medication Use Among an Epidemiological Cohort of Youth
Susanna Visser, M.S.
Centers for Disease Control and Prevention, Atlanta, GA
Steven P. Cuffe, M.D.
University of Florida College of Medicine- Jacksonville, Jacksonville, FL
Joseph R. Holbrook, M.P.H.
University of South Carolina, Arnold School of Public Health, Columbia, SC
Robert E. McKeown, Ph.D.
University of South Carolina, Arnold School of Public Health, Columbia, SC
3.60
Mental Disorders in Orphanage and Suspected Contributing Risk Factors
Caroline Widiaty, M.D.
University of Indonesia, Jakarta Indonesia
3.61
Latest Clinical Trials in Child and Adolescent Psychiatry: What Kind of Trials and What Kinds of Treatments?
Aarti Gupta, M.D.
University of Texas at Houston, Houston, TX
Jatinder Mohan Chawla, M.D.
SUNY DOWNSTATE MEDICAL CENTER, Brooklyn, NY
Rajeev Mahajan, M.B.B.S., M.S.
Thomas Jefferson University, Philadelphia, PA
Angelica Kloos, D.O.
Thomas Jefferson University, Philadelphia, PA
Ashutosh Atri, M.D.
University of Texas at Houston, Houston, TX
Rajnish Mago, M.D.
Thomas Jefferson University, Philadelphia, PA
3.62
Influencing Medication Prescribing for Arkansas' Children through Off-Label Education
Mark E. Helm, M.D., M.B.A.
Helm Benefit Design, Little Rock, AR
3.63
A Prospective Open-Label Trial of Quetiapine Monotherapy in Preschool and School Age Children with Bipolar Spectrum Disorder
Gagan Joshi, M.D.
Massachusetts General Hospital, Boston, MA
Carter Petty, M.A.
Massachusetts General Hospital, Boston, MA
Janet Wozniak, M.D.
, Lexington, MA
Sarah Walls, B.A.
Massachusetts General Hospital, Cambridge, MA
Breanna Glaeser, B.S.
Massachusetts General Hospital, Cambridge, MA
Dayna M. Yorks, B.A.
Massachusetts General Hospital, Cambridge, MA
Joseph Biederman, M.D.
Massachusetts General Hospital, Boston, MA
3.64
Suicidality Assessment in Pediatric Placebo-Controlled Studies of Ziprasidone
Onur N. Karayal, M.D., M.P.H.
Pfizer, Inc, New York, NY
Susan D. Anway, DVM
Pfizer, Inc, New London, CT
Evan Batzar, M.S.
Pfizer, Inc, New York, NY
Douglas G. Vanderburg, M.D., M.P.H.
Pfizer, Inc, New York, NY
